Patentee Disclosed Colitis Treatment In Clinical Trial Data, Petitioner Alleges
ALEXANDRIA, Va. — Samsung Bioepis Co. Ltd. tells the Patent Trial and Appeal Board in a June 21 petition for inter partes review (IPR) that various claims of a patented method...To view the full article, register now.
Already a subscriber? Click here to view full article